| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |